Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Kuan-Pin Su
JCP
Original Research
Benzodiazepine Use Possibly Increases Cancer Risk: A Population-Based Retrospective Cohort Study in Taiwan
JCP
Original Research
Change in Employment Status in Bipolar Disorder: A Longitudinal Study Using National Claims Data
JCP
Letter to the Editor
A Crossover Study of Prolactin Changes Associated With Risperidone and Olanzapine
JCP
Letter to the Editor
Elevated Plasma Clozapine Concentrations After Phenobarbital Discontinuation
JCP
Letter to the Editor
Long-Acting Injectable Risperidone and Hospital Readmission: A Mirror-Image Study Using a National Claim-Based Database in Taiwan
JCP
Original Research
A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids
JCP
Academic Highlights
A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Dementia
JCP
Article
Omega-3 Fatty Acids for Major Depressive Disorder During Pregnancy: Results From a Randomized, Double-Blind, Placebo-Controlled Trial
JCP
Letter to the Editor
Personalized Medicine With Omega-3 Fatty Acids for Depression in Children and Pregnant Women and Depression Associated With Inflammation
JCP
Letter to the Editor
A Pilot Observational Crossover Study of QTc Interval Changes Associated With Switching Between Olanzapine and Risperidone
JCP
Letter to the Editor
Seizures After Discontinuation of Low-Dose Lorazepam From Originally Seizure-Free Clozapine Regimen: Combined Effects?
JCP
Letter to the Editor
Transcranial Magnetic Stimulation for OCD
Read a case discussing repetitive transcranial magnetic stimulation (rTMS) as a potential therapy for major depressive disorder and obsessive-compulsive disorder.
JCP
Meta-Analysis
Omega-3 PUFA Supplements for ADHD
Although omega-3 polyunsaturated fatty acids (PUFAs) may not improve core symptoms of attention-deficit/hyperactivity disorder, longer-term PUFA supplementation may have potential benefits.